WallStreetZenWallStreetZen

NYSEMKT: IGC
Igc Pharma Inc Stock Ownership - Who owns Igc Pharma?

Insider buying vs selling

Have Igc Pharma Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when IGC insiders and whales buy or sell their stock.

IGC Shareholders

What type of owners hold Igc Pharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ram Mukunda7.47%4,761,763$2.33MInsider
Db Zwirn Co LP2.33%1,485,404$727.85kInsider
Richard K. Prins1.95%1,242,917$609.03kInsider
Ranga C. Krishna1.68%1,068,461$523.55kInsider
Claudia Grimaldi1.63%1,037,154$508.21kInsider
Steven Michael Oliveira1.21%772,196$378.38kInsider
Blackrock Inc1.13%717,884$351.76kInstitution
Sudhakar V. Shenoy1.09%695,000$340.55kInsider
Vanguard Group Inc1.01%645,166$316.13kInstitution
Ranga Krishna0.74%470,000$230.30kInsider

1 of 3

IGC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IGC3.87%20.14%
SPRB63.59%36.41%Net SellingNet Selling
NRXP6.23%93.77%Net Buying
APRE1.54%98.46%Net BuyingNet Buying
PTN8.26%91.74%Net SellingNet Selling

Igc Pharma Stock Ownership FAQ

Who owns Igc Pharma?

Igc Pharma (NYSEMKT: IGC) is owned by 3.87% institutional shareholders, 20.14% Igc Pharma insiders, and 75.98% retail investors. Ram Mukunda is the largest individual Igc Pharma shareholder, owning 4.76M shares representing 7.47% of the company. Ram Mukunda's Igc Pharma shares are currently valued at $2.12M.

If you're new to stock investing, here's how to buy Igc Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.